Serum OPG levels as indicators of periodontitis severity

Summarised from:

Serum osteoprotegerin and periodontal destruction in subjects with type 1 diabetes mellitus
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.12129)

Authors:

Georgios Antonoglou, Matti Knuuttila, Pentti Nieminen, Olli Vainio, Liisa Hiltunen, Taina Raunio, Onni Niemelä, Pirjo Hedberg, Riitta Karttunen, Tellervo Tervonen

Summarised by:

Dr Dominika Antoniszczak

Research Topic:

Background + Aims

  • Periodontitis is a chronic inflammatory disease that leads to tissue and bone destruction. It is more severe in individuals living with type 1 diabetes mellitus (T1DM) due to heightened systemic inflammation.
  • Osteoprotegerin (OPG) is a regulator of bone metabolism and inflammation. Serum OPG levels may reflect tissue destruction in systemic inflammatory conditions, including periodontitis and diabetes.
  • This study aimed to examine whether serum OPG and soluble receptor activator of nuclear factor kappa B ligand (sRANKL) levels are associated with periodontal inflammation and tissue destruction in people with T1DM.
  • Researchers hypothesised that serum OPG levels would correlate with the severity of periodontal destruction, while sRANKL and the sRANKL/OPG ratio would also be linked to periodontal status.

Materials + Methods

  • A cross-sectional study conducted on 80 participants with T1DM (aged 18–74 years) from healthcare facilities in Finland.
  • Data Collection:
    • Clinical periodontal examination assessed probing pocket depth (PPD), attachment loss (AL), and bleeding on probing (BOP).
    • Serum OPG and sRANKL levels were measured using ELISA.
    • Glycaemic management was evaluated using three-year and one-year averages of HbA1c levels.
  • Participant Groups:
    • Classified based on periodontal severity (no/mild, moderate, severe).
    • Smokers and non-smokers were analysed separately due to the confounding effect of smoking.
  • Statistical Analysis:
    • Linear regression models tested the association between periodontal parameters and serum markers.
    • Adjustments were made for age, gender, body mass index (BMI), smoking, and glycaemic control.

Results

  • Serum OPG levels were positively correlated with periodontal attachment loss and severity of periodontitis.
  • Subjects with severe periodontitis had higher OPG levels (135 pg/ml) compared to those with mild/no periodontitis (96 pg/ml).
  • There was no significant association between serum sRANKL and sRANKL/OPG with periodontal inflammation or tissue destruction.
  • Smokers showed weaker associations between OPG and periodontitis, potentially due to residual confounding or reduced sample size in non-smoking analysis.
  • Age and HbA1c levels showed modest correlations with OPG levels.
  • The findings suggest that serum OPG is a systemic marker of periodontal tissue destruction in individuals with T1DM.

Limitations

  • The study cannot establish causality between serum OPG levels and periodontal destruction.
  • The study lacked individuals without diabetes as control group, limiting comparisons of OPG and sRANKL levels between those with and without diabetes.
  • The small sample size reduced statistical power, particularly in subgroup analyses (e.g., non-smokers).
  • Smoking was assessed as a binary variable rather than by lifetime exposure, which may have led to residual confounding.
  • The study was conducted in a specific Finnish population, limiting applicability to other populations.
  • Local periodontal markers were not assessed, preventing comparisons between local and systemic inflammatory responses.

Conclusion

  • Serum OPG levels are significantly associated with periodontal tissue destruction in individuals with T1DM, making it a potential systemic marker of periodontal severity.
  • No significant associations were found for sRANKL or the sRANKL/OPG ratio.
  • These findings highlight the importance of managing periodontitis in people living with diabetes to reduce systemic inflammatory burden.
Read the full article Back to Research

Research  |  19.05.13

clock icon 5 mins to read

Share this page:

Copy Link

You might also like...

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on…

Read more

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on the relationship between diabetes and oral health.

Read more

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more
icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Successful periodontal treatment can improve blood glucose control

Our Team

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Education & Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Outreach & Communications Lead

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Periodontitis-Diabetes Hub Position: Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Periodontitis-Diabetes Hub Position: Education and Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Periodontitis-Diabetes Hub Position: Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Periodontitis-Diabetes Hub Position: Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Periodontitis-Diabetes Hub Position: Outreach and Communications Lead

View All